Summary of opinion: Retsevmo, 26/03/2026 Positive
Submitted by Anonymous (not verified) on 27 March 2026 - 11:46
Summary of opinion: Retsevmo, 26/03/2026 Positive
Summary of opinion: Retsevmo, 26/03/2026 Positive
Summary of opinion: Hetronifly, 26/03/2026 Positive
Summary of opinion: Hetronifly, 26/03/2026 Positive
Summary of opinion: Capvaxive, 26/03/2026 Positive
Summary of opinion: Feraccru, 26/03/2026 Positive
Summary of opinion: Besponsa, 26/03/2026 Positive
Human medicines European public assessment report (EPAR): Adstiladrin, nadofaragene firadenovec, Status: Opinion
Human medicines European public assessment report (EPAR): Imdylltra, tarlatamab, Status: Opinion
Human medicines European public assessment report (EPAR): Bopediat, furosemide, Status: Opinion
Human medicines European public assessment report (EPAR): Zepzelca, lurbinectedin, Status: Opinion